fig2

Serum TUBB is a potential biomarker for the diagnosis of non-small cell lung cancer

Figure 2. Comparative examination of serum proteomic profiles across distinct groups. (A) Typical mass spectrum for a subject with NSCLC, depicted in red; (B) Typical mass spectrum for a healthy control, depicted in green; (C) Aggregated spectra within the 1-10 kDa mass range derived from healthy controls (green) and NSCLC (red) groups. (D) Visual representation of mass spectra, known as Gel view, comparing samples from NSCLC patients with those from healthy individuals.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/